Table 5.
Awareness and Treatment of HCV Infection
| Variable | Anti-HCV-positive persons | HCV RNA-positive persons* | |||
|---|---|---|---|---|---|
| Yes | p-value | Yes | p-value | ||
| Diagnosed as hepatitis C by a doctor | |||||
| All responders | 15.2 (35/230) | 30.5 (18/59) | |||
| Age group, yr | 0.310 | 0.768 | |||
| <40 | 3.8 (1/26) | 0.0 (0/2) | |||
| 40–49 | 24.0 (6/25) | 50.0 (2/4) | |||
| 50–59 | 13.0 (7/54) | 25.0 (3/11) | |||
| 60–69 | 18.5 (10/54) | 33.3 (5/15) | |||
| ≥70 | 15.5 (11/71) | 30.8 (8/26) | |||
| Sex | 0.179 | 0.084 | |||
| Male | 18.8 (19/101) | 43.5 (10/23) | |||
| Female | 12.4 (16/129) | 22.2 (8/36) | |||
| Area of residence | 0.651 | 0.755 | |||
| Rural | 16.9 (11/65) | 33.3 (6/18) | |||
| Urban | 14.5 (24/165) | 29.3 (12/41) | |||
| Education | 0.102 | 0.005 | |||
| <High school | 12.2 (17/139) | 18.9 (7/37) | |||
| ≥High school | 20.2 (18/89) | 55.5 (11/20) | |||
| Family income | 0.209 | 0.575 | |||
| Low to mid-low | 17.8 (24/135) | 32.6 (14/43) | |||
| Mid-high to high | 11.7 (11/94) | 25.0 (4/16) | |||
| Prevalence of anti-HCV | 0.289 | 0.354 | |||
| Lower prevalent area | 13.8 (24/174) | 26.8 (11/41) | |||
| Higher prevalent area | 19.6 (11/56) | 38.9 (7/18) | |||
| ALT, U/L | 0.082 | 0.592 | |||
| <40 | 13.4 (26/194) | 28.2 (11/39) | |||
| ≥40 | 25.0 (9/36) | 35.0 (7/20) | |||
| Treatment for HCV infection | 5.2 (12/230) | 13.5 (8/59) | |||
Data are presented as percent (number/number).
HCV, hepatitis C virus; ALT, alanine aminotransferase.
*HCV RNA was measured between 2012 and 2015.